Venlafaxine-lithium toxicity: Suitability for use in the elderly

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 5, 2007, Pages 529-531

  Gillman, Ken ^a  

^a Pioneer Valley Private Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORTRIPTYLINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

DISEASE SEVERITY; DRUG FATALITY; DRUG METABOLISM; DRUG POTENCY; DRUG RESPONSE; DRUG SENSITIVITY; GERIATRIC PATIENT; HUMAN; LETTER; MYOCLONUS; NEUROLOGIC DISEASE; ORGANIC BRAIN SYNDROME; PRESSOR RESPONSE; SEIZURE; SEROTONIN TOXICITY; UNSPECIFIED SIDE EFFECT;

AGED; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; FEMALE; HUMANS; LITHIUM COMPOUNDS; RISK; SEROTONIN SYNDROME;

EID: 34548647142     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00830.x     Document Type: Letter

References (29)

1. Adan-Manes J, Novalbos J, Lopez-Rodriguez R, Ayuso-Mateos JL, Abad-Santos F (2006) Lithium and venlafaxine interaction: a case of serotonin syndrome. Journal of Clinical Pharmacy and Therapeutics, 31, 397 400.
2. Buckley N (2002) Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. British Medical Journal, 325, 1332 1333.
3. Whyte IM, Dawson AH, Buckley NA (2003) Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. Quarterly Journal of Medicine, 96, 369 374.
4. Whyte IM (2004) Serotonin Toxicity (Syndrome). In: Dart RC, ed. Medical toxicology. Baltimore: Lippincott Williams & Wilkins, 103 106.
5. Isbister GK, Bowe SJ, Dawson A, Whyte IM (2004) Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Journal of Toxicology. Clinical Toxicology 42, 277 285
6. Dunkley EJC, Isbister GK, Sibbritt D, Dawson AH, Whyte IM (2003) Hunter serotonin toxicity criteria: a simple and accurate diagnostic decision rule for serotonin toxicity. Quarterly Journal of Medicine, 96, 635 642.
7. Gillman PK (2006) Serotonin toxicity, serotonin syndrome: 2006 update, overview and analysis. http://www.psychotropical.com/ST_doc_request.shtml, Epub 1-125. (Accessed July 2006)
8. Graudins A, Stearman A, Chan B (1998) Treatment of the serotonin syndrome with cyproheptadine. Journal of Emergency Medicine, 16, 615 619.
9. Brubacher JR, Hoffman RS, Lurin MJ (1996) Serotonin syndrome from venlafaxine-tranylcypromine interaction. Veterinary and Human Toxicology, 38, 358 361.
10. Diamond S, Pepper BJ, Diamond ML, Freitag FG, Urban GJ, Erdemoglu AK (1998) Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports. Neurology, 51, 274 276.
11. Zonneveld AM, Hagenaars M, Voermans NC, Gelissen HP, Claassen JA (2006) [Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor]. Nederlands Tijdschrift Voor Geneeskunde, 150, 1081 1084.
12. Hawley CJ, Loughlin PJ, Quick SJ et al. (2000) Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence. Hertfordshire Neuroscience Research Group. International Clinical Psychopharmacology, 15, 197 206.
13. Zerjav-Lacombe S, Dewan V (2001) Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine. Annals of Pharmacotherapy, 35, 180 182.
14. McKeith I, Mintzer J, Aarsland D et al. (2004) Dementia with Lewy bodies. Lancet Neurology, 3, 19 28.
15. Baskys A (2004) Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. Journal of Clinical Psychiatry, 65 (Suppl. 11 16 22.
16. Macritchie KAN, Young AH (2004) Adverse syndromes associated with lithium. In: Haddad P, Dursun S, Deakin B, eds. Adverse syndromes and psychiatric drugs. Oxford: Oxford University Press, 89 124.
17. Montanes-Rada F, Bilbao-Garay J, de Lucas-Taracena M, Ortiz-Ortiz M (2005) Venlafaxine, serotonin syndrome, and differential diagnoses. Journal of Clinical Psychopharmacology, 25, 101 102.
18. Lu TC, Chu PL, Wu CS, Tsai KC, Chen WJ (2006) Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. Journal of the Formosan Medical Association, 105, 90 93.
19. Tsai HC, Kuo PH, Yang PC (2003) Fever, consciousness disturbance, and muscle rigidity in a 68-year-old man with depressive disorder. Chest, 124, 1598 1601.
20. Nimmagadda SR, Ryan DH, Atkin SL (2000) Neuroleptic malignant syndrome after venlafaxine. Lancet, 355, 289 290.
21. Isbister GK (2003 Comment: combination risperidone and SSRI-induced serotonin syndrome. Annals of Pharmacotherapy, 37, 1531 1532 author reply 1532-1533.
22. Isbister GK, Whyte IM (2002) Atypical presentation of risperidone toxicity. Veterinary and Human Toxicology, 44, 118 119.
23. Whyte IM, Isbister GK (2001) Misdiagnosis of myoclonus in antidepressant induced serotonin excess. Veterinary and Human Toxicology, 43, 375 376.
24. Gillman PK (1998) Serotonin syndrome: history and risk. Fundamental and Clinical Pharmacology, 12, 482 491.
25. Gillman PK (2005) Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al. Journal of Clinical Psychopharmacology, 25, 625 626.
26. Meyer JH, Wilson AA, Sagrati S et al. (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. American Journal of Psychiatry, 161, 826 835.
27. Blier P, Saint-Andre E, Hebert C, de Montigny C, Lavoie N, Debonnel G (2007) Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. International Journal of Neuropsychopharmacology, 10, 41 50
28. Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie, 58, 447 474.
29. Gillman PK (2006) A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biological Psychiatry, 59, 1046 1051.